newsfilter
← Latest News
PR Newswire·

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

Movano Health (NASDAQ: MOVE) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's ...